292 
Increased B Cells Counts in Chronic HIV Disease during ART Is Associated with Disappearance of Apoptosis-prone B Cell Subsets
Susan Moir*, A Malaspina, J Ho, A DiPoto, S Kottilil, G Roby, A O'Shea, J Mican, T W Chun, and A Fauci
NIAID, NIH, Bethesda, MD, US
Background: HIV disease progression is associated with the appearance
of 2 distinct populations of B cells: immature/transitional
B cells that arise as a result of CD4+ T-cell lymphopenia,
and mature/activated B cells that arise as a result of HIV-induced immune
activation. Both populations were previously shown to be unresponsive to
various B-cell stimuli. The effect of ART on B-cell counts and population
dynamics was investigated in the setting of chronic HIV disease.
Methods: B cells of 13 HIV chronically infected ART-naïve
individuals were evaluated before and after initiation of ART. Lymphocyte
counts and HIV plasma viremia were monitored for 1
year, along with changes in sub-populations of B cells. The subpopulations of B
cells were evaluated in terms of phenotype, cell turnover, expression of
survival factors, and susceptibility to apoptosis.
Results: After initiation of ART, HIV plasma viremia
declined to undetectable levels within 3 to 4 months while CD4+
T-cell counts increased by 30%, reaching 42% recovery by 1 year. Unexpectedly, the rise in B-cell counts was not
significantly different than that of CD4+ T-cell counts, 32% after 3
to 4 months and 34% by 1 year. Prior to the initiation of ART, >50% of the B
cells were comprised of immature/transitional and mature/activated B cells,
compared to <15% in uninfected individuals. After 1 year on ART, profiles of
B-cell populations were similar to those of uninfected individuals. Functional
characterization revealed that immature/transitional B cells were highly
susceptible to intrinsic apoptosis associated with reduced expression of
pro-survival members of the Bcl-2 family, whereas mature/activated B cells
expressed increased levels of Ki-67 and were highly susceptible to extrinsic
apoptosis associated with increased expression of CD95.
Conclusions: We provide evidence of increases in B-cell counts in
chronically infected HIV-infected individuals following reduction of HIV plasma
viremia by ART that paralleled increases in CD4+
T-cell counts. Given that the increases in total B-cell counts were associated
with the disappearance of apoptosis-prone B-cell populations, these data
suggest that loss of B cells during ongoing HIV replication may in part be due
to increased B-cell death.
|